Most Recent
Canadian generic manufacturer Apotex has agreed to drop its lawsuit against India's Cipla seeking to invalidate its Australian patent for popular nasal spray Dymista.
The Commissioner of Patents will seek to toss a case simultaneously challenging its decisions to accept, grant and certify an innovation patent owned by one of Australia's biggest building product firms.
The companies that own some of Australia's largest intellectual property boutiques have agreed to a merger that will create a 349 employee-strong firm that's a force to be reckoned with in the market for IP services in Asia Pacific.
The Paris-based publisher of Elle Magazine has succeeded in a challenge to a trade mark application by an Australian building supplier for the name of its brand of bathroom fixtures, 'Ella'.
Generic drug maker Dr Reddy's Laboratories has reached a settlement with US-based Millennium Pharmaceuticals, agreeing to be restrained from selling a cheap version of cancer drug Velcade in Australia.
Confectionery giant Mars has successfully opposed an application by Kraft Foods for an Australian patent for chocolate that doesn't melt in the summer months.
The company that manufactures Botox alternatives has denied infringing on Allergan's Botox trade mark, telling a court Wednesday its use of the word was for comparative purposes only.
US-based Millennium Pharmaceuticals has secured a temporary injunction that bans generic drug maker Juno Pharmaceuticals from importing or selling its cheap version of breakthrough cancer drug Velcade in Australia.
An urgent injunction sought by US-based Millennium Pharmaceuticals to block generic drug maker Dr Reddy's Laboratories from launching a cheap version of the breakthrough cancer drug Velcade has been panned as unnecessary.
Two patent infringement lawsuits have been launched over attempts to sell generic versions of breakthrough cancer drug Velcade in Australia, after a US court last year struck down attempts to invalidate a patent for the drug.